LONDON COMMISSIONING REGION
C/O NHS ENGLAND, 1W09, 1ST FLOOR, QUARRY HOUSE, QUARRY HILL, LEEDS, WEST YORKSHIRE See member list for this organisation
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2012 | 10351 | 12226 | 84.7% | |
| HF 4 | 2013 | 10812 | 12299 | 87.9% | |
| HF004 | 2014 | 6757 | 7305 | 92.5% | |
| HF004 | 2015 | 7823 | 8342 | 93.8% | |
| HF004 | 2016 | 9384 | 9972 | 94.1% | |
| HF004 | 2017 | 10539 | 11169 | 94.4% | |
| HF004 | 2018 | 11507 | 12260 | 93.9% | |
| HF004 | 2019 | 12900 | 13754 | 93.8% | |
| HF004 | 2020 | 13771 | 14828 | 92.9% | |
| HF006 | 2021 | 16911 | 18605 | 90.9% | |
| HF006 | 2022 | 18880 | 19765 | 95.5% | |
| HF006 | 2023 | 21716 | 22393 | 97.0% |
